Autopsy report · NCT02036307
Supplementation With Omega-3: Mechanism of Action
Cause of deathFunding or business
“This study was suspended because there is no more funds to complete the study.”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 1 year 9 months before it stopped.
- 13 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Conditions
- Hypertriglyceridemia
- Interventions
- DHA-enriched; EPA-enriched
- Participants
- 13
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Dim Light at Night in Patients With Obstructive Sleep Apnea
“The study was stopped due to lack of funding.” - Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
“Study Was Terminated due to lack of Funding.” - Health Education for Physiotherapy in Soccer Players
“The study was stopped by insufficient funds” - Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
“Study suspended due to low accrual” - Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
“The study was stopped because of lack of funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.